Practices evolution on psychotropic drugs prescriptions: Atypical antipsychotic drugs position;Évolution des pratiques de prescription des psychotropes en centre hospitalier psychiatrique: Place des neuroleptiques atypiques

Journal de Pharmacie Clinique

Volumn 24, Issue 1, 2005, Pages 5-10

  Orhon Menard S ^a   Garcel, A ^a   De Beauchamp, I ^a   Spitz, F ^a  

^a CENTRE HOSPITALIER   (France)

Author keywords

Antipsychotic drug; Evolution; Prescription; Psychiatry; Psychotropic drug

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZAMIDE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; CYAMEMAZINE; HALOPERIDOL; HYPNOTIC AGENT; LEVOMEPROMAZINE; LOXAPINE; NEUROLEPTIC AGENT; NOCTRAN; OLANZAPINE; PHENOTHIAZINE DERIVATIVE; PSYCHOTROPIC AGENT; RISPERIDONE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; THIOXANTHENE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL PRACTICE; DEPRESSION; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERANCE; DRUG UTILIZATION; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MONOTHERAPY; PRACTICE GUIDELINE; PRESCRIPTION; SCHIZOPHRENIA;

EID: 16344369081     PISSN: 02911981     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gury C, Berchot F, Fabre C, Surugue J, Welcomme N. Analyse des prescriptions de neuroleptiques dans cinq centres hospitaliers spécialisés. Comparaison entre prescriptions hospitalières et prescriptions de sorties. Inf Psychiatr 2000; 76: 954-63.
2. Bret P, Bonnet F, Bret MC, Jaffre A. Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis or prescribing practices for amisulpride, clozapine, olanzapine and risperidone. L'Encéphale 2002; 28: 329-42.
3. Brunot A, Lachaux B, Sontag H, Casadebaig F, Philippe A, Rouillon F, et al. Étude pharmaco-épidémiologique de la prescription des antipsychotiques en milieu psychiatrique en France. L'Encéphale 2002; 28: 129-38.
4. Catalan J, Gathe D, Bond A. General practice patients on long term psychotropics drugs. Br J Psychiatry 1988; 152: 399-405.
5. Baldessarini RJ, Kando JC, Centorrino F. Hospital use af antipsychotic agents in 1989 ond 1993: stable dosing with decreased length of stay. Am J Psychiatry 1995; 152: 1038-44.
6. Muijen M, Silversone T. A comparative hospital survery of psychotropic drug prescribing. Br J Psychiatry 1987; 37: 29-36.
7. Holloway F. Prescribing for the long term mentally ill. A study of treatment practice. Br J Psychiatry 1988; 152: 511-5.
8. Morgan R. Psychotropic drugs: other survery of prescribing patterns. Br J Psychiatry 1984; 144: 289-302.
9. Tapp A, Wood AE, Secrest L, Erdmann J, Cubberley L, Kilzieh N. Combination antipsychotic therapy in clinical practice. Psychiatr Serv 2003; 54: 55-9.
10. Schumacher JE, Makela EH, Griffin HR. Multiple antipsychotic medication prescribing patterns. Ann Pharmacother 2003; 37: 951-5.
11. Stratégies thérapeutiques à long terme dans les psychoses chroniques. Conférence de consensus des 13 et 14 janvier 1994. http://psydoc-fr.broca.inserm.fr consulté le 26 juillet 2004.
12. Schizophrénies débutantes: diagnostics et modalités thérapeutiques - Conférence de consensus des 23 et 24 janvier 2003. http://psydoc-fr.broca.inserm.fr consultė le 26 juillet 2004.
13. Dupire B, Perrin S. De l'association de neuroleptiques: entre théorie et pratique. Synapse 1993; 94: 60-5.
14. Lalonde P. Evaluating antipsychotic medications: predictors of clinical effectiveness. Report of an expert review panel on efficacy and effectiveness. Can J Psychiatry 2003; 48: 3S-12S.
15. Azouin JM. L'association de neuroleptiques. Synapse 1995; n° spécial XIXth CINP Congress Washington: 38-42.
16. Ayd FJ. Early onset neuroleptics-induced extrapyramidal reaction: a second survey 1961-1981. In: Neuroleptics: neurochemical, behavioral and clinical perspectives. New York: Raven Press, 1983: 75-92.
17. Wolf MA, Villeneuve A. Les effets indésirables des neuroleptiques. L'Encephale 1990; 16: 111-24.
18. Palazzolo J, Lachaux B. Entre compliance et liberté: le témoignage d'un patient. L'Encéphale 1999; 25: 477-84.
19. Moore A, Sellwood W, Stirling J. Compliance and psychological reactance in schizophrenia. Br J Clin Psychiatry 2000; 39: 287-95.
20. Gelenberg AJ. Treating extrapyramidal reactions: some current issues. J Clin Psychiatry 1987; 48: 24-7.
21. Van Putten T. Why do schizophrenic patient refuse to take their drugs? Arch Gen Psychiatry Assoc 1972; 17: 69-72.
22. Rifkin A, Quitkikn F, Kane J, Stuve F, Klein DF. Are prophylactic antiparkinson drugs necessary? A controlled study of procyclidine withdrawal. Arch Gen Psychiatry 1978; 35: 4833-9.
23. Danel P, Petit H. Les anticholinergiques au cours des traitements neuroleptiques. Concours Med 1989; 111: 543-5.
24. Pochat MD, Lemoine P. Bien prescrire les psychatropes: les neuroleptiques II. Concours Med 1991; 113: 3431-4.
25. Ben Hadj ali B, Dogui M, Ben Ammou S, Loo H. Les antiparkinsoniens au cours du traitement neuroleptique: étude comparative des modes de sevrage progressif et brutal. L'Encéphale 1995; 20: 209-15.
26. Parepally H, Chakravorty S, Levine J, Brar JS, Patel AM, Baird JW, et al. The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic ogents: a naturalistic study at a state psychiatric hospital. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 437-40.
27. Manus A. Critères cliniques pour le choix d'un antidépresseur. L'Encéphale 1995; (Suppl. 4): 19-21.
28. Parquet PJ, Lhuillier JP, Malauzat D. La qualité de vie chez les patients psychotiques hospitalisés. Synapse 1994; 105: 89-92.